7G0O

Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 2-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5-dimethylthiophen-2-yl]carbamoyl]cyclohexene-1-carboxylic acid

Experimental procedure

Experimental method	SINGLE WAVELENGTH
Source type	SYNCHROTRON
Source details	SLS BEAMLINE X10SA
Synchrotron site	SLS
Beamline	X10SA
Temperature [K]	100
Detector technology	PIXEL
Collection date	2012-08-21
Detector	PSI PILATUS 6M
Wavelength(s)	0.700030
Spacegroup name	P 2 21 21
Unit cell lengths	32.115, 52.750, 72.365
Unit cell angles	90.00, 90.00, 90.00

Refinement procedure

Resolution	42.630 - 1.320
R-factor	0.1738
Rwork	0.171
R-free	0.22950
Structure solution method	MOLECULAR REPLACEMENT
Starting model (for MR)	inhouse model
RMSD bond length	0.015
RMSD bond angle	1.843
Data reduction software	XDS
Data scaling software	XSCALE
Phasing software	PHASER
Refinement software	REFMAC (5.7.0029)

Data quality characteristics

	Overall	Inner shell	Outer shell
Low resolution limit [Å]	42.630	42.630	1.350
High resolution limit [Å]	1.320	5.900	1.320
Rmerge	0.116	0.038	1.696
Rmeas	0.148	0.042	1.846
Total number of observations	186657
Number of reflections	29694	402	2134
<I/σ(I)>	7.58	31.41	1.07
Completeness [%]	100.0	98.5	99.9
Redundancy	6.36	5.692	6.382
CC(1/2)	0.997	0.999	0.304

Crystallization Conditions

crystal ID	method	pH	temperature	details
1	VAPOR DIFFUSION, SITTING DROP	7	293	protein in 25mM Tris/HCl pH 7.5 100mM NaCl, see also PMID 27658368